Drug
Ursolic acid
Ursolic acid is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_2
2
40%
Ph early_phase_1
2
40%
Ph phase_1
1
20%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Withdrawn2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 12 (40.0%)
Phase 11 (20.0%)
Phase 22 (40.0%)
Trials by Status
completed360%
withdrawn240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
NCT05776862
withdrawnearly_phase_1
Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate
NCT04403568
completedearly_phase_1
Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid
NCT04421716
completedphase_2
Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome
NCT02337933
withdrawnphase_1
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
NCT03216876
Clinical Trials (5)
Showing 5 of 5 trials
NCT05776862Phase 2
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
NCT04403568Early Phase 1
Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate
NCT04421716Early Phase 1
Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid
NCT02337933Phase 2
Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome
NCT03216876Phase 1
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5